Overview

Medical Aesthetics Market Introduction:

Medical Aesthetics Market is estimated to value over USD 18.5 billion by 2027 end and register a CAGR of over 10% during the forecast period 2020 to 2027. 

 Medical aesthetic devices are used for treating a person’s impairments related to aesthetic appearances like unwanted hair, cellulite, scars, spider veins, excessive fat, skin discoloration, moles, skin laxity, wrinkles and liver spots. Aesthetic medicines include both non-surgical and surgical procedures and physicians may choose a combination of both to intensify the patient’s physical appearance. Convenient replacement of missing or dysfunctional body parts caused by trauma, accidents and other congenital disorders is possible by the usage of medical aesthetic implants.

Technological advancements, increase in demand for non-invasive or minimally invasive reconstruction surgical operations, increase in trauma cases and road accidents, high incidence of breast cancer, rise in number of cosmetology surgeons, high prevalence of congenital face and tooth deformities and increase in the number of awareness programs like breast reconstructive awareness campaign, which was initiated in the United States, steer the medical aesthetic devices market growth. Although, low reimbursements, high treatment costs, and risk of implant-associated malfunctions are primary factors that restrain this market growth. Rise in popularity of celebrities amongst the young population who encourage them to look aesthetically appealing, increase in preference for a better quality of life, growing medical tourism and are expected to provide numerous lucrative opportunities for market players which shall expand the medical aesthetics market size.

Key players included in the global medical aesthetics market industry are Allergan, Alma Lasers Ltd., Anika Therapeutics Inc., Cutera Inc., Cynosure, El.En S.P.A, Fotona D.O.O, Galderma, Johnson & Johnson, Merz Aesthetics Inc., Medytox Inc., Sientra Inc., Sinclair Pharma PLC, Solta Medical, Syneron Medical Ltd. 

Medical Aesthetics Market Segmentation:

By Product

•  Facial Aesthetic Products
•  Botulinum Toxin
•  Dermal Filters
•  Natural Dermal Filters
•  Synthetic Dermal Filters
•  Chemical Peels
•  Microdermabrasion Devices
•  Body Contouring Devices
•  Non-Surgical Fat Reduction Devices
•  Cellulite Reduction Devices
•  Liposuction Devices
•  Cosmetic Implants
•  Breast Implants
•  Silicone Breast Implants
•  Saline Breast Implants
•  Facial Implants
•  Other Cosmetic Implants
•  Physician-Dispensed Cosmeceuticals and Skin Lighteners
•  Skin Aesthetic Devices
•  Laser Skin Resurfacing Devices
•  Non-Surgical Skin Tightening Devices
•  Micro-Needling Products
•  Light Therapy Devices
•  Physician-Dispensed Eyelash Products
•  Hair Removal Devices
•  Laser hair Removal Devices
•  IPL Hair Removal Devices
•  Tattoo Removal Devices
•  Thread Lift Products
•  Nail Treatment Laser Devices

By End User

• Clinics, Hospitals and Medical S.P.A. s
• Beauty Centres
• Home Care Settings

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

FutureWise Key Takeaways: 

•  Growth prospects
•  SWOT analysis 
•  Key trends 
•  Key data-points affecting market growth 

Objectives of the Study:

• To provide with an exhaustive analysis on the global medical aesthetics market by product, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Geographic Scope

           1.3.3 Years Considered for the Study

    1.4 Currency Used for the Study 

    1.5 Stakeholders 

2 Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Data

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Data

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Breakdown of Primaries

    2.2 Market Estimation Methodology 

           2.2.1 Revenue-Based Market Estimation

           2.2.2 Procedure-Based Market Estimation

           2.2.3 Primary Research Validation

    2.3 Market Breakdown and Data Triangulation 

    2.4 Research Assumptions and Limitations 

           2.4.1 Assumptions

           2.4.2 Limitations

3 Executive Summary 

4 Premium Insights 

    4.1 Medical Aesthetics: Market Overview 

    4.2 Market, By Product (USD Million) 

    4.3 Regional Analysis: Market, By End User 

    4.4 Geographic Snapshot of the Market 

    4.5 Worldwide Medical Aesthetics Procedures Data (2020) 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures

                    5.2.1.2 Rising Adoption Among Geriatric Individuals

                    5.2.1.3 Increasing Public Awareness About Cosmetic Procedures

                    5.2.1.4 Availability of Technologically Advanced and User-Friendly Products

                    5.2.1.5 Increasing Demand for Aesthetic Treatments Among Men

           5.2.2 Restraints

                    5.2.2.1 Clinical Risks and Complications Associated With Medical Aesthetic Procedures

                    5.2.2.2 Increasing Availability and Adoption of Alternative Beauty and Cosmetic Products

           5.2.3 Opportunities

                    5.2.3.1 Emerging Markets

                    5.2.3.2 Development of Low-Cost Medical Aesthetic Devices

                    5.2.3.3 Growing Adoption of Home-Use Aesthetic Devices

                    5.2.3.4 Increasing Disposable Incomes and the Expanding Middle-Class Population

           5.2.4 Challenges

                    5.2.4.1 Social and Ethical Issues Associated With Cosmetic Treatments

6 Medical Aesthetics Market, By Product   

 6.1 Introduction 

    6.2 Facial Aesthetic Products 

           6.2.1 Botulinum Toxin

           6.2.2 Dermal Fillers

                    6.2.2.1 Natural Dermal Fillers

                    6.2.2.2 Synthetic Dermal Fillers

           6.2.3 Chemical Peels

           6.2.4 Microdermabrasion Devices

    6.3 Body Contouring Devices 

           6.3.1 Nonsurgical Fat Reduction Devices

           6.3.2 Cellulite Reduction Devices

           6.3.3 Liposuction Devices

    6.4 Cosmetic Implants 

           6.4.1 Breast Implants

                    6.4.1.1 Silicone Breast Implants

                    6.4.1.2 Saline Breast Implants

           6.4.2 Facial Implants

           6.4.3 Other Cosmetic Implants

    6.5 Physician-Dispensed Cosmeceuticals and Skin Lighteners 

    6.6 Skin Aesthetic Devices 

           6.6.1 Laser Skin Resurfacing Devices

           6.6.2 Nonsurgical Skin Tightening Devices

           6.6.3 Micro-Needling Products

           6.6.4 Light Therapy Devices

    6.7 Physician-Dispensed Eyelash Products 

    6.8 Hair Removal Devices 

           6.8.1 Laser Hair Removal Devices

           6.8.2 IPL Hair Removal Devices

    6.9 Tattoo Removal Devices 

    6.1 Thread Lift Products 

    6.11 Nail Treatment Laser Devices 

7 Medical Aesthetics Market, By End User 

    7.1 Introduction 

    7.2 Clinics, Hospitals, and Medical S.P.A.s 

    7.3 Beauty Centers 

    7.4 Home Care Settings 

8 Medical Aesthetics Market, By Region 

    8.1 Introduction 

    8.2 North America 

           8.2.1 Market Dynamics

                    8.2.1.1 Launch and Approvals for Aesthetic Devices

                    8.2.1.2 Rapidly Increasing Aging and Obese Population in the US and Canada

                    8.2.1.3 Rich Research Pipeline

                    8.2.1.4 Lack of Reimbursement and High Cost of Aesthetic Procedures

           8.2.2 US

           8.2.3 Canada

    8.3 Europe 

           8.3.1 Market Dynamics

                    8.3.1.1 Launch of Novel Aesthetic Products

                    8.3.1.2 High Use of Dermal Fillers in Europe

                    8.3.1.3 Conferences and Training Programs

                    8.3.1.4 Growing Focus of Market Companies on the European Market

                    8.3.1.5 Dearth of Pertinent Regulatory Guidelines

                    8.3.1.6 Slow Market Growth Due to Reimbursement Issues

           8.3.2 Germany

           8.3.3 France

           8.3.4 UK

           8.3.5 Rest of Europe

    8.4 Asia Pacific 

           8.4.1 Market Dynamics

                    8.4.1.1 Growing Middle-Class Population and Purchasing Power in the Region

                    8.4.1.2 Growing Preference for Aesthetic Surgery in South Korea

                    8.4.1.3 Growing Uses of Neurotoxins

                    8.4.1.4 Lack of Reimbursements

           8.4.2 Japan

           8.4.3 China

           8.4.4 South Korea

           8.4.5 India

           8.4.6 Rest of APAC

    8.5 Rest of the World 

           8.5.1 Market Dynamics

                    8.5.1.1 Rise in Medical Tourism

                    8.5.1.2 Increasing Number of Aesthetic Procedures in the Region

                    8.5.1.3 Weak Economy and Low Consumer Buying Power in Latam and African Countries

                    8.5.1.4 Shortage of Plastic Surgeons in the Middle East and Africa

           8.5.2 Latin America

           8.5.3 Middle East

           8.5.4 Africa

9 Competitive Landscape 

    9.1 Introduction 

    9.2 Global Market Share Analysis (2020) 

           9.2.1 Global Market Share Analysis for Facial Aesthetic Products

           9.2.2 Global Market Share Analysis for Energy & Light-Based Devices

           9.2.3 Global Market Share Analysis for Cosmetic Implants

    9.3 Competitive Scenario 

           9.3.1 Key Product Launches and Approvals (2017–2020)

           9.3.2 Agreements, Partnerships, Collaborations (2017–2020)

           9.3.3 Acquisitions (2017–2020)

           9.3.4 Expansions (2017–2020)

           9.3.5 Investments and Divestments (2017–2020)

10 Company Profiles 

     10.1 Allergan 

     10.2 Alma Lasers, Ltd. (A Division of Sisram Medical Ltd.) 

     10.3 Anika Therapeutics, Inc. 

     10.4 Cutera, Inc. 

     10.5 Cynosure (A Wholly Owned Subsidiary of Hologic, Inc.) 

     10.6 El.En. S.P.A. 

     10.7 Fotona D.O.O. 

     10.8 Galderma (A Subsidiary of Nestlé) 

     10.9 Johnson & Johnson 

     10.10 Merz Aesthetics, Inc. (A Division of Merz Pharma GmbH & Co. KGaA) 

     10.11 Medytox, Inc. 

     10.12 Sientra, Inc. 

     10.13 Sinclair Pharma PLC  

     10.14 Solta Medical (A Division of Valeant Pharmaceuticals International, Inc.) 

     10.15 Syneron Medical, Ltd. (A Part of Apax Partners)

Chapter 12 Research Finding and Conclusion 

Chapter 13  Research Methodology 

Chapter 14  Research Data Source   

Tables

Figures